Ocuphire Pharma Stock Forecast - Naive Prediction

OCUPDelisted Stock  USD 1.13  0.06  5.04%   
The Naive Prediction forecasted value of Ocuphire Pharma on the next trading day is expected to be 1.20 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.03. Ocuphire Stock Forecast is based on your current time horizon.
  
A naive forecasting model for Ocuphire Pharma is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Ocuphire Pharma value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Ocuphire Pharma Naive Prediction Price Forecast For the 3rd of December

Given 90 days horizon, the Naive Prediction forecasted value of Ocuphire Pharma on the next trading day is expected to be 1.20 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 3.03.
Please note that although there have been many attempts to predict Ocuphire Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Ocuphire Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Ocuphire Pharma Stock Forecast Pattern

Backtest Ocuphire PharmaOcuphire Pharma Price PredictionBuy or Sell Advice 

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Ocuphire Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Ocuphire Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria112.6926
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0496
MAPEMean absolute percentage error0.0367
SAESum of the absolute errors3.0276
This model is not at all useful as a medium-long range forecasting tool of Ocuphire Pharma. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Ocuphire Pharma. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Ocuphire Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ocuphire Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ocuphire Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.134.84
Details
Intrinsic
Valuation
LowRealHigh
0.061.124.83
Details

View Ocuphire Pharma Related Equities

 Risk & Return  Correlation

Ocuphire Pharma Market Strength Events

Market strength indicators help investors to evaluate how Ocuphire Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ocuphire Pharma shares will generate the highest return on investment. By undertsting and applying Ocuphire Pharma stock market strength indicators, traders can identify Ocuphire Pharma entry and exit signals to maximize returns.

Ocuphire Pharma Risk Indicators

The analysis of Ocuphire Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Ocuphire Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ocuphire stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Ocuphire Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocuphire Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ocuphire Stock

  0.68BKRKF PT Bank RakyatPairCorr

Moving against Ocuphire Stock

  0.85HD Home DepotPairCorr
  0.83CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.8PTAIF PT Astra InternationalPairCorr
  0.75AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.72T ATT Inc Fiscal Year End 22nd of January 2025 PairCorr
The ability to find closely correlated positions to Ocuphire Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocuphire Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocuphire Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocuphire Pharma to buy it.
The correlation of Ocuphire Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocuphire Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocuphire Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocuphire Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Ocuphire Stock

If you are still planning to invest in Ocuphire Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ocuphire Pharma's history and understand the potential risks before investing.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities